These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 29270777)
1. Association Between Polymorphisms in the Promoter Region of microRNA-34b/c and the Chemoradiotherapy Efficacy for Locally Advanced Esophageal Squamous Cell Carcinoma in Chinese Han Population. Bulibu J; Wang W; Tang Y; Li N; Saifuding K Pathol Oncol Res; 2019 Jan; 25(1):421-427. PubMed ID: 29270777 [TBL] [Abstract][Full Text] [Related]
2. Pri-miR-124 rs531564 and pri-miR-34b/c rs4938723 polymorphisms are associated with decreased risk of esophageal squamous cell carcinoma in Chinese populations. Zhang J; Huang X; Xiao J; Yang Y; Zhou Y; Wang X; Liu Q; Yang J; Wang M; Qiu L; Zheng Y; Zhang P; Li J; Wang Y; Wei Q; Jin L; Wang J; Wang M PLoS One; 2014; 9(6):e100055. PubMed ID: 24945256 [TBL] [Abstract][Full Text] [Related]
3. Genetic variation in miR-100 rs1834306 is associated with decreased risk for esophageal squamous cell carcinoma in Kazakh patients in northwest China. Zhu J; Yang L; You W; Cui X; Chen Y; Hu J; Liu W; Li S; Song X; Wei Y; Zhang W; Li F Int J Clin Exp Pathol; 2015; 8(6):7332-40. PubMed ID: 26261633 [TBL] [Abstract][Full Text] [Related]
4. Hsa-miR-34b/c rs4938723 T>C and hsa-miR-423 rs6505162 C>A polymorphisms are associated with the risk of esophageal cancer in a Chinese population. Yin J; Wang X; Zheng L; Shi Y; Wang L; Shao A; Tang W; Ding G; Liu C; Liu R; Chen S; Gu H PLoS One; 2013; 8(11):e80570. PubMed ID: 24260422 [TBL] [Abstract][Full Text] [Related]
5. Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk. Yuan F; Sun R; Chen P; Liang Y; Ni S; Quan Y; Huang J; Zhang L; Gao L Tumour Biol; 2016 May; 37(5):6267-73. PubMed ID: 26619844 [TBL] [Abstract][Full Text] [Related]
6. The correlation between XIAP gene polymorphisms and esophageal squamous cell carcinoma susceptibility and prognosis in a Chinese population. Peng H; Wang LG; Wang XZ; Liu AJ Pathol Res Pract; 2017 Dec; 213(12):1482-1488. PubMed ID: 29037837 [TBL] [Abstract][Full Text] [Related]
7. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma. Wang WT; Guo CQ; Cui GH; Zhao S World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161 [TBL] [Abstract][Full Text] [Related]
8. miR-449b rs10061133 and miR-4293 rs12220909 polymorphisms are associated with decreased esophageal squamous cell carcinoma in a Chinese population. Zhang P; Wang J; Lu T; Wang X; Zheng Y; Guo S; Yang Y; Wang M; Kolluri VK; Qiu L; Shen F; Fan L; Li J; Wang Y; Wei Q; Jin L; Wang J; Wang M Tumour Biol; 2015 Nov; 36(11):8789-95. PubMed ID: 26055141 [TBL] [Abstract][Full Text] [Related]
9. Promoter polymorphisms of miR-34b/c are associated with risk of gastric cancer in a Chinese population. Yang C; Ma X; Liu D; Wang Y; Tang R; Zhu Y; Xu Z; Yang L Tumour Biol; 2014 Dec; 35(12):12545-54. PubMed ID: 25190020 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-1322 regulates ECRG2 allele specifically and acts as a potential biomarker in patients with esophageal squamous cell carcinoma. Zhang T; Zhao D; Wang Q; Yu X; Cui Y; Guo L; Lu SH Mol Carcinog; 2013 Aug; 52(8):581-90. PubMed ID: 22315007 [TBL] [Abstract][Full Text] [Related]
11. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development. Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858 [TBL] [Abstract][Full Text] [Related]
12. A Genetic Variant in miR-124 Decreased the Susceptibility to Esophageal Squamous Cell Carcinoma in a Chinese Kazakh Population. Wu F; Li M; You W; Ji Y; Cui X; Hu J; Chen Y; Pang L; Li S; Wei Y; Yang L; Li F Genet Test Mol Biomarkers; 2018 Jan; 22(1):29-34. PubMed ID: 29227754 [TBL] [Abstract][Full Text] [Related]
13. Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma. He FC; Meng WW; Qu YH; Zhou MX; He J; Lv P; Ming L World J Gastroenterol; 2015 Apr; 21(15):4660-5. PubMed ID: 25914476 [TBL] [Abstract][Full Text] [Related]
14. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma. Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784 [TBL] [Abstract][Full Text] [Related]
15. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with renal cell cancer risk in a Chinese population. Zhang S; Qian J; Cao Q; Li P; Wang M; Wang J; Ju X; Meng X; Lu Q; Shao P; Zhang Z; Qin C; Yin C Mutagenesis; 2014 Mar; 29(2):149-54. PubMed ID: 24503183 [TBL] [Abstract][Full Text] [Related]
16. Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients. Tan HZ; Wu ZY; Wu JY; Long L; Jiao JW; Peng YH; Xu YW; Li SS; Wang W; Zhang JJ; Li EM; Xu LY BMC Cancer; 2016 Jul; 16():560. PubMed ID: 27472962 [TBL] [Abstract][Full Text] [Related]
17. Interactions of miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma. Li L; Wu J; Sima X; Bai P; Deng W; Deng X; Zhang L; Gao L Tumour Biol; 2013 Jun; 34(3):1919-23. PubMed ID: 23504554 [TBL] [Abstract][Full Text] [Related]
18. Pri-miR-34b/c rs4938723 Polymorphism Contributes to Coronary Artery Disease Susceptibility. Cen J; Xiong Q; Yang X; Guo J; Xiong XD; Zhang A Arch Med Res; 2019 May; 50(4):170-174. PubMed ID: 31499476 [TBL] [Abstract][Full Text] [Related]
19. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma. Xu Y; Liu L; Liu J; Zhang Y; Zhu J; Chen J; Liu S; Liu Z; Shi H; Shen H; Hu Z Int J Cancer; 2011 Jan; 128(2):412-7. PubMed ID: 20309940 [TBL] [Abstract][Full Text] [Related]
20. Plasma miR-185 is decreased in patients with esophageal squamous cell carcinoma and might suppress tumor migration and invasion by targeting RAGE. Jing R; Chen W; Wang H; Ju S; Cong H; Sun B; Jin Q; Chu S; Xu L; Cui M Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(9):G719-29. PubMed ID: 26316588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]